Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-19-060089

Options or other derivatives

  • Chief Executive Officer acquired 617,024.37 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Michelon Francois Roger · Chief Executive Officer

Table II: Derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-11 Grant or award : show line 1 in the form Stock option (right to buy) +611,994 611,994 D
2019-12-11 Grant or award : show line 2 in the form Series A Convertible Preferred Stock +4.37 $1,143.68 $5,000 4.37 D
2019-12-11 Grant or award : show line 3 in the form Warrants +5,026 5,026 D
Loading xslF345X03/doc4.xml…